Artgen Biotech PJSC (MOEX:ISKJ)

Artgen Biotech PJSC Balance Sheet

Financials in millions RUB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	344.49	503.35	544.94	201.66	193.29	107.39
Trading Asset Securities	-	35.11	27.39	25.4	0.51	0.51
Cash & Short-Term Investments	344.49	538.46	572.33	227.06	193.8	107.9
Cash Growth	-12.77%	-5.92%	152.07%	17.16%	79.61%	-39.49%
Accounts Receivable	113.47	67.3	81.83	67.86	83.2	90.18
Other Receivables	81.35	52.33	72.58	61.69	23.92	41.98
Receivables	194.82	189.6	205.38	185.11	131.76	151.46
Inventory	262.96	246.84	226.31	223.87	245.79	233.54
Other Current Assets	248.5	97.94	113.22	53.74	86.71	83.04
Total Current Assets	1,051	1,073	1,117	689.77	658.06	575.93
Property, Plant & Equipment	396.69	376.86	315.87	280.51	285	330.25
Long-Term Investments	92.37	96.91	161.33	193.34	120.62	54.35
Other Intangible Assets	866.67	347.92	174.9	150.1	128.6	116.93
Long-Term Deferred Tax Assets	124.55	115.23	90.83	83.03	86.12	76.03
Long-Term Deferred Charges	-	510.21	631.35	586.62	414.09	342.11
Total Assets	2,750	2,671	2,544	2,045	1,737	1,512
Accounts Payable	83.96	54.92	53.41	33.87	35.94	35.38
Short-Term Debt	-	-	0.73	0.73	0.2	0.19
Current Portion of Long-Term Debt	26.88	87.71	219.72	106.44	-	177.77
Current Portion of Leases	26.01	25.17	19.53	11.69	8.89	9.91
Current Income Taxes Payable	22.07	15	24.84	24.57	14.61	10.7
Other Current Liabilities	217.37	286.11	243.16	218.28	312.52	322.18
Total Current Liabilities	376.29	468.91	561.4	395.57	372.15	556.13
Long-Term Debt	504.76	480.5	427.2	601.38	494.23	175
Long-Term Leases	128.17	144.28	119.77	111.36	113.82	125.59
Other Long-Term Liabilities	511.12	504.13	460.96	366	296.49	240.38
Total Liabilities	1,520	1,598	1,569	1,474	1,277	1,097
Common Stock	9.27	9.27	9.27	9.27	8.5	7.5
Additional Paid-In Capital	638.87	626.58	625.13	612.1	567.43	151.93
Retained Earnings	481	365.43	241.53	146.45	94.13	69.42
Treasury Stock	-495.37	-499.39	-421.99	-447.85	-446.98	-34.97
Comprehensive Income & Other	-94.51	-94.51	-30.06	21.07	11.7	0.38
Total Common Equity	539.25	407.37	423.87	341.04	234.78	194.26
Minority Interest	690.18	666.25	550.86	229.22	225.78	220.74
Shareholders' Equity	1,229	1,074	974.73	570.26	460.56	415
Total Liabilities & Equity	2,750	2,671	2,544	2,045	1,737	1,512
Total Debt	685.82	737.65	786.96	831.6	617.13	488.46
Net Cash (Debt)	-341.33	-199.2	-214.62	-604.55	-423.33	-380.56
Net Cash Per Share	-3.66	-2.15	-2.32	-6.96	-5.29	-5.07
Filing Date Shares Outstanding	73.79	73.76	75.15	81.61	85	75
Total Common Shares Outstanding	73.79	73.76	75.15	81.61	85	75
Working Capital	674.48	603.94	555.84	294.2	285.9	19.81
Book Value Per Share	7.31	5.52	5.64	4.18	2.76	2.59
Tangible Book Value	-327.41	59.45	248.97	190.94	106.18	77.33
Tangible Book Value Per Share	-4.44	0.81	3.31	2.34	1.25	1.03
Buildings	-	63.02	67.06	49.65	97.89	94.08
Machinery	-	419.13	375.42	353.72	336.45	325.07
Construction In Progress	-	16.15	-	-	0.05	0.9

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.